TrumpRx website using technology from GoodRx, STAT says

President Trump is planning to announce the launch of his TrumpRx website, which uses technology from health care company GoodRx (GDRX), on Thursday night as part of his plan to lower drug prices in the U.S., reported STAT News’ Elaine Chen, John Wilkerson, and Chelsea Cirruzzo. The website is expected to display the cash prices for certain drugs and direct patients to other sites where they can buy the therapies, but some experts are skeptical the platform will meaningfully affect affordability, the report noted. Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).